Informations générales (source: ClinicalTrials.gov)
Genetics of Central Nervous System Arteriovenous Malformations (AVM): Genotype-phenotype Correlation and Prognostic Impact on Patients with AVM (GENE-MAV)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
février 2022
octobre 2026
22 novembre 2024
Cerebral and medullary arteriovenous malformations (AVMs) lead to arterial and venous
networks to communicate pathologically, creating an arteriovenous shunt. The occurrence
of intracranial haemorrhage is the most important prognostic factor of AVMs because it is
associated with a significant morbidity and mortality. The genetic, molecular and
cellular mechanisms that cause vascular malformations of the central nervous system are
partially known and the influence of genetic damage on the prognosis of AVMs is poorly
known.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL FOCH | GEORGES RODESCH | 05/05/2025 07:12:09 | Contacter | ||
| HOPITAL FONDATION A. DE ROTHSCHILD | Stanislas SMAJDA | 21/06/2024 13:34:11 | Contacter | ||
Critères
Tous
Inclusion Criteria:
- Patient with a vascular malformation of the cerebral or medullary identified on
diagnostic imaging (angio-CT, angio-MRI or diagnostic angiography) for which
clinical monitoring alone or intervention (endovascular treatment, surgery or
radiosurgery) is planned in the centres participating in the research.
- Patient with a vascular malformation of the cerebral or medullary identified on
diagnostic imaging (angio-CT, angio-MRI or diagnostic angiography) for which
clinical monitoring alone or intervention (endovascular treatment, surgery or
radiosurgery) is planned in the centres participating in the research.
- Pregnant, parturient or breastfeeding woman